Predictors of Response to Autologous Dendritic Cell Therapy in Glioblastoma Multiforme

BACKGROUND: Glioblastoma (GBM) is the most common and lethal primary malignant glioma in adults. Dendritic cell (DC) vaccines have demonstrated promising results in GBM clinical trials. However, some patients do not respond well to DC therapy, with survival rates similar to those of conventional the...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Immunol
Main Authors: Jan, Chia-Ing, Tsai, Wan-Chen, Harn, Horng-Jyh, Shyu, Woei-Cherng, Liu, Ming-Chao, Lu, Hsin-Man, Chiu, Shao-Chih, Cho, Der-Yang
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2018
Assuntos:
Immunology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5992384/
https://ncbi.nlm.nih.gov/pubmed/29910795
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.00727
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados